PatientsVille.com Logo

Bronchopneumonia and Ospamox

PatientsVille

Bronchopneumonia Symptoms and Causes

Pneumonia is an infection in one or both of the lungs. Many germs, such as bacteria, viruses, and fungi, can cause pneumonia. You can also get pneumonia by inhaling a liquid or chemical. People most at risk are older than 65 or younger than 2 years of age, or already have health problems.

Symptoms of pneumonia vary from mild to severe. See your doctor promptly if you

  • Have a high fever
  • Have shaking chills
  • Have a cough with phlegm that doesn't improve or gets worse
  • Develop shortness of breath with normal daily activities
  • Have chest pain when you breathe or cough
  • Feel suddenly worse after a cold or the flu

Your doctor will use your medical history, a physical exam, and lab tests to diagnose pneumonia. Treatment depends on what kind you have. If bacteria are the cause, antibiotics should help. If you have viral pneumonia, your doctor may prescribe an antiviral medicine to treat it.

Preventing pneumonia is always better than treating it. Vaccines are available to prevent pneumococcal pneumonia and the flu. Other preventive measures include washing your hands frequently and not smoking.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for bronchopneumonia

bronchopneumonia treatment research studies

Ospamox clinical trials, surveys and public health registries


Find Drug Side Effect reports



Ospamox Side Effects

Pruritus (11)
Headache (10)
Dyspnoea (8)
Abdominal Pain (6)
Hyperhidrosis (5)
Cough (4)
Chest Pain (4)
Local Swelling (3)
Dysphagia (2)
Suffocation Feeling (2)
Enanthema (1)
Fatigue (1)
Tongue Oedema (1)
Erythema (1)
Epileptic Aura (1)
Choking Sensation (1)
Diarrhoea Haemorrhagic (1)
Hypersensitivity (1)
Lip Swelling (1)
Lip Oedema (1)
Petechiae (1)
Purulent Discharge (1)
Rash Pustular (1)
Rash (1)
Stupor (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Bronchopneumonia Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Duration of Antibiotic Therapy in Community - Acquired Pneumonia
Conditions: Pneumonia;   Bronchopneumonia;   Pleuropneumonia;   Pneumonia, Bacterial;   Pneumonia, Viral
Intervention: Other: Discontinuation of antibiotic therapy
Outcome Measures: Composite outcome including adverse events;   Composite outcome of other adverse events;   Antibiotic exposure;   Adverse effects;   Composite outcome of other adverse events at 90 days;   Length of hospitalization;   Costs
2 Unknown  Efficacy and Safety of Split-dose Citrafleet Administered From 2 to 6 Hours Before Morning Colonoscopies
Conditions: Bowel Cleansing;   Colonoscopy
Interventions: Drug: Sodium picosulphate, magnesium oxid and citric acid;   Drug: Sodium picosulphate/magnesium oxide and citric acid
Outcome Measures: Degree of bowel cleansing (Boston Scale 0-3) in each anatomical segment of the colon;   Rate of aspiration Bronchopneumonia;   Adenoma detection rate
3 Recruiting PTH - Preemptive Treatment for Herpesviridae
Condition: Viral Pneumonia
Interventions: Drug: Aciclovir;   Drug: Ganciclovir;   Drug: Placebo
Outcome Measures: Ventilator-free days at Day 60;   Day 60 mortality;   ICU mortality;   Hospital mortality;   Duration of mechanical ventilation in survivors;   Duration of ICU stay;   Duration of hospital stay;   Incidence of ventilator-associated pneumonia;   Incidence of bacteremia;   SOFA score;   Acute renal failure related to aciclovir or its placebo;   Leucopenia related to ganciclovir or its placebo;   Time to oropharyngeal negativation of HSV PCR;   Time to blood negativation of CMV PCR;   Incidence of herpetic Bronchopneumonia;   Incidence of active CMV infection
4 Recruiting Impact of Early Goal-directed Fluid Therapy in Septic Patients Undergoing Emergency Surgery
Conditions: Severe Sepsis;   Emergency;   Surgery
Interventions: Other: CONTROL;   Other: OPTIMIZED
Outcome Measures: Delta lactate;   Cardiovascular complications: myocardial infarct or congestive heart failure;   Cerebral complications: stroke;   Pulmonary complications: ALI/ARDS, Bronchopneumonia;   Pulmonary complications: respiratory insufficiency necessitating re-intubation;   Surgical complications: re-operation for bleeding or infection;   Renal complications: infection, urosepsis or renal insufficiency;   Duration of post-operative mechanical ventilation: in hours;   Total duration of ventilation : days;   Length of stay in the ICU: in days;   Length of stay in hospital: in days;   Mortality;   SOFA score measurement;   Death;   Number of unexpected ICU admission
5 Recruiting Impact of Early Goal-directed Fluid Therapy in Hypovolemic Patients Undergoing Emergency Surgery
Conditions: Hypovolemic Shock;   Trauma;   Emergency;   Surgery
Interventions: Other: CONTROL;   Other: OPTIMIZED
Outcome Measures: Delta lactate;   Cardiovascular complications: myocardial infarct or congestive heart failure;   Cerebral complications: stroke;   Pulmonary complications: ALI/ARDS, Bronchopneumonia;   Pulmonary complications: respiratory insufficiency necessitating re-intubation;   Surgical complications: re-operation for bleeding or infection;   Renal complications: infection, urosepsis or renal insufficiency;   Duration of post-operative mechanical ventilation: in hours;   Total duration of ventilation : days;   Length of stay in the ICU: in days;   Length of stay in hospital: in days;   Mortality;   SOFA score measurement;   Death;   Number of unexpected ICU admission
6 Recruiting Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis
Condition: Bronchopulmonary Infection
Intervention: Other: sputum samples
Outcome Measure: A taking of expectorations